Summary Liquid biopsy using circulating tumor DNA (ctDNA) is increasingly used for cancer profiling and monitoring, but blood-based analysis may not capture tumor heterogeneity across anatomical compartments. We evaluated cell-free DNA from cerebrospinal (n = 7), pleural (n = 11), pericardial (n = 1), and ascitic (n =...
A. Shreenivas, S. Limaye, M. Cristofanilli et al.· iScience· 0 citations
Precision oncology has transformed cancer care globally through biomarker-driven and genomically guided treatment strategies. In Asia, where nearly 60% of the world’s population resides, the implementation of molecular profiling presents both significant opportunities and unique challenges. Despite increasing adoption,...
S. Limaye, H. Loong, Mahin Bhatt et al.· Journal of Immunotherapy and...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.